Tuohy V K, Fritz R B, Ben-Nun A
Cleveland Clinic Foundation, Department of Immunology, OH 44195.
Curr Opin Immunol. 1994 Dec;6(6):887-91. doi: 10.1016/0952-7915(94)90009-4.
Recent research developments support the following views regarding antigen recognition in autoimmune demyelinating disease: there may be no single autoimmune target protein; diverse peptide self-determinants from multiple myelin proteins can be recognized; target determinant epitopes may differ among individuals; and target epitope recognition can change with time during the course of disease.